Infantile epilepsy syndrome
MONDO:0020071An epilepsy syndrome that occurs between 28 days to one year of life.
Also known as: epilepsy syndrome of infancy, infantile epilepsy syndrome, infantile onset epilepsy syndrome
17 clinical trials for this condition and its sub-types, 2 tagged with Infantile epilepsy syndrome itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Infantile epilepsy syndrome
-
Undetermined early-onset epileptic encephalopathy 1 trial · 6 incl. sub-types
16 sub-types
- Developmental and epileptic encephalopathy, 13 3 trials
- Developmental and epileptic encephalopathy, 25 1 trial
- Developmental and epileptic encephalopathy, 42 1 trial
- Developmental and epileptic encephalopathy, 21 0 trials
- Developmental and epileptic encephalopathy, 24 0 trials
- Developmental and epileptic encephalopathy, 26 0 trials
- Developmental and epileptic encephalopathy, 28 0 trials
- Developmental and epileptic encephalopathy, 29 0 trials
- Developmental and epileptic encephalopathy, 31A 0 trials
- Developmental and epileptic encephalopathy, 32 0 trials
- Developmental and epileptic encephalopathy, 33 0 trials
- Developmental and epileptic encephalopathy, 41 0 trials
- Developmental and epileptic encephalopathy, 44 0 trials
- Developmental and epileptic encephalopathy, 45 0 trials
- Developmental and epileptic encephalopathy, 46 0 trials
- Developmental and epileptic encephalopathy, 47 0 trials
-
Benign partial infantile seizures 0 trials
5 sub-types
- Benign familial infantile epilepsy 0 trials Sub-types →
- Benign infantile focal epilepsy with midline spikes and wave during sleep 0 trials
- Benign infantile seizures associated with mild gastroenteritis 0 trials
- Benign non-familial infantile seizures 0 trials Sub-types →
- Infantile convulsions and choreoathetosis 0 trials
-
Myoclonic epilepsy in infancy 0 trials
Most studied deeper sub-types
-
Promising seizure drug study halted early
Disease control Stopped earlyThis study looked at the long-term safety of the drug NBI-921352 for people with a rare genetic seizure disorder called SCN8A-DEE. It was an extension of an earlier study, and participants took the drug alongside their usual seizure medications. The study was stopped early and on…
Phase 2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Promising epilepsy drug trial halted early – what we know
Disease control Stopped earlyThis study tested an experimental drug called NBI-921352 in people aged 2 to 21 with a rare, severe form of epilepsy caused by a change in the SCN8A gene. The goal was to see if adding this drug to their current seizure medicines could reduce how often they had seizures. The tria…
Phase 2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC